Related Experiment Video
Updated: Aug 11, 2026

Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy
Published on: June 25, 2013
Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium
1Department of Anesthesiology, Case Western Reserve University, Cleveland, Ohio 44109, USA.
Purpose:
To evaluate the tracheal intubating conditions and neuromuscular blocking characteristics of divided dose mivacurium or single dose rocuronium.
Methods:
Thirty-two patients undergoing elective surgery were studied. Anaesthesia was with propofol 2 mg.kg-1, followed by an infusion of 150 micrograms.kg-1.min.1. Patients were randomized to receive either mivacurium-0.15 mg.kg-1 followed 30 sec later by 0.1 mg.kg-1, or rocuronium- 0.9 mg.kg-1, followed 30 sec later by placebo. Tracheal intubating conditions were assessed 90 sec after the initial dose of relaxant by an anaesthetists who was unaware of patient group. The electromyographic (EMG) response of the first dorsal interosseus muscle to ulnar nerve train-of-four was measured.
Results:
Successful tracheal intubation was performed in all patients after both mivacurium and rocuronium. Intubating conditions (jaw relaxation, open visible vocal cords) were judged to be good-excellent in all but one patient before insertion of the tracheal tube. However, patients receiving mivacurium were more likely to experience coughing and bucking after tracheal tube insertion (10/16 patients) than those receiving rocuronium (3/16 patients, P < 0.05). No patient in the rocuronium group experienced moderately vigorous coughing and bucking after insertion of the tracheal tube vs six patients in the mivacurium group (P < 0.05). Time to 10 and 25% recovery of neuromuscular function was faster (P < 0.05) after divided dose mivacurium (20 +/- 1 and 23 +/- 1 min, respectively) than after rocuronium (45 +/- 5 and 57 +/- 8 min, respectively).
Conclusion:
The results suggest that, during conditions of the study, divided dose mivacurium is not recommended for a 90-sec tracheal intubation in patients where moderate coughing and bucking is deemed unacceptable.
Insights
Divided dose mivacurium is not recommended for 90-second tracheal intubation when coughing is unacceptable. Rocuronium provided similar intubating conditions with less post-intubation coughing and faster neuromuscular recovery.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Neuromuscular blocking agents are crucial for endotracheal intubation.
- Mivacurium and rocuronium are commonly used non-depolarizing neuromuscular blockers.
Purpose of the Study:
- To compare tracheal intubating conditions and neuromuscular blocking characteristics of divided dose mivacurium versus single dose rocuronium.
Main Methods:
- A randomized study of 32 patients undergoing elective surgery.
- Anesthesia induced with propofol and maintained with infusion.
- Patients received either divided dose mivacurium or single dose rocuronium.
- Tracheal intubation assessed 90 seconds post-initial dose; neuromuscular function monitored via EMG.
Main Results:
- Both mivacurium and rocuronium provided good-to-excellent intubating conditions in all patients.
- Mivacurium group had significantly more coughing and bucking post-intubation (10/16 vs 3/16).
- Neuromuscular function recovery was faster with mivacurium (10% recovery at 20 min) than rocuronium (10% recovery at 45 min).
Conclusions:
- Divided dose mivacurium is not recommended for 90-second tracheal intubation if coughing and bucking are unacceptable.
- Rocuronium offers comparable intubating conditions with a lower incidence of adverse airway reflexes.
Related Concept Videos
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics
Skeletal Muscle Relaxants: Therapeutic Uses

